The following reagents and instruments were used: 5% TNBS (Sigma, St Louis, MO, United States); phospho (p)MEK antibody (Cell Signaling Technology, Danvers, MA, United States);
pERK antibody (Cell Signaling Technology);
pCREB antibody (Cell Signaling Technology); MEK inhibitor U0126 (Calbiochem, Darmstadt, Germany);
DMSO (Santa Cruz Biotechnology, Dallas, TX, United States); horseradish peroxidase goat anti-rabbit IgG (Beyotime, Shanghai, China);
Von Frey filaments (Stoelting Co, Wood Dale, IL, United States); BME2410A thermal stimulator (Institute of Medical Biology, Chinese Academy of Medical Sciences, Beijing, China); electrophoresis system:
Mini-PROTEAN 3 cell (Bio-Rad, Hercules, CA, United States); imaging system: ChemiDoc
TM (Bio-Rad, Hercules, CA, United States); PCR primers
ABI 7300 (Thermo Fisher Scientific, Waltham, MA, United States).
Li Z.Y., Huang Y., Yang Y.T., Zhang D., Zhao Y., Hong J., Liu J., Wu L.J., Zhang C.H., Wu H.G., Zhang J, & Ma X.P. (2017). Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats. World Journal of Gastroenterology, 23(34), 6220-6230.